LT4778B - Dezinfekavimo kompozicija - Google Patents
Dezinfekavimo kompozicija Download PDFInfo
- Publication number
- LT4778B LT4778B LT2000087A LT2000087A LT4778B LT 4778 B LT4778 B LT 4778B LT 2000087 A LT2000087 A LT 2000087A LT 2000087 A LT2000087 A LT 2000087A LT 4778 B LT4778 B LT 4778B
- Authority
- LT
- Lithuania
- Prior art keywords
- composition
- weight
- alcohol
- disinfectant
- water
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 230000000249 desinfective effect Effects 0.000 title abstract description 7
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims abstract description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 claims abstract description 20
- 229940068939 glyceryl monolaurate Drugs 0.000 claims abstract description 17
- 239000000645 desinfectant Substances 0.000 claims description 39
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 claims description 19
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000416 hydrocolloid Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 description 13
- 239000008267 milk Substances 0.000 description 13
- 210000004080 milk Anatomy 0.000 description 13
- 210000002445 nipple Anatomy 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 230000003641 microbiacidal effect Effects 0.000 description 12
- 241000283690 Bos taurus Species 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 210000000481 breast Anatomy 0.000 description 10
- 244000005700 microbiome Species 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
- 230000002779 inactivation Effects 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000004599 antimicrobial Substances 0.000 description 6
- 210000000265 leukocyte Anatomy 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000011835 investigation Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000194031 Enterococcus faecium Species 0.000 description 4
- 241000588770 Proteus mirabilis Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- -1 propylene glycol monosaccharic acid Chemical compound 0.000 description 3
- 210000001082 somatic cell Anatomy 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 230000002925 chemical effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- CRDAMVZIKSXKFV-YFVJMOTDSA-N (2-trans,6-trans)-farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- DWKQNRUYIOGYLP-UHFFFAOYSA-N 3-methyl-2-pentylphenol Chemical compound CCCCCC1=C(C)C=CC=C1O DWKQNRUYIOGYLP-UHFFFAOYSA-N 0.000 description 1
- 150000005168 4-hydroxybenzoic acids Chemical class 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002402 hexoses Chemical group 0.000 description 1
- 230000003165 hydrotropic effect Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940124561 microbicide Drugs 0.000 description 1
- 239000002855 microbicide agent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000004957 nitroimidazoles Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000006208 topical dosage form Substances 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/04—Oxygen or sulfur attached to an aliphatic side-chain of a carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK38798 | 1998-03-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LT2000087A LT2000087A (lt) | 2001-01-25 |
| LT4778B true LT4778B (lt) | 2001-04-25 |
Family
ID=8092930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LT2000087A LT4778B (lt) | 1998-03-19 | 2000-09-14 | Dezinfekavimo kompozicija |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6414023B1 (xx) |
| EP (1) | EP1063886B1 (xx) |
| AT (1) | ATE233484T1 (xx) |
| AU (1) | AU740138B2 (xx) |
| CA (1) | CA2321658C (xx) |
| DE (1) | DE69905700T2 (xx) |
| DK (1) | DK1063886T3 (xx) |
| EE (1) | EE04136B1 (xx) |
| ES (1) | ES2191417T3 (xx) |
| IL (1) | IL137891A (xx) |
| LT (1) | LT4778B (xx) |
| LV (1) | LV12582B (xx) |
| NO (1) | NO323049B1 (xx) |
| NZ (1) | NZ506681A (xx) |
| PL (1) | PL196077B1 (xx) |
| PT (1) | PT1063886E (xx) |
| RU (1) | RU2221557C2 (xx) |
| WO (1) | WO1999046987A1 (xx) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070003508A1 (en) | 2005-07-01 | 2007-01-04 | Wooley Richard E | Methods and compositions for promoting wound healing |
| US20040208842A1 (en) * | 2001-09-18 | 2004-10-21 | Ritchie Branson W. | Antimicrobial cleansing compositions and methods of use |
| US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
| US20100056628A1 (en) * | 2006-09-07 | 2010-03-04 | Stockel Richard F | Preservative compositions |
| US8795638B1 (en) | 2003-08-26 | 2014-08-05 | Nevada Naturals Inc. | Compositions for dental care |
| US8193244B1 (en) | 2008-05-29 | 2012-06-05 | Nevada Naturals, Inc. | Antimicrobial agents |
| US20050058673A1 (en) | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
| WO2005091967A2 (en) * | 2004-03-03 | 2005-10-06 | University Of Georgia Research Foundation, Inc. | Methods and compositions for ophthalmic treatment of fungal and bacterial infections |
| CN101137359B (zh) | 2005-03-10 | 2011-01-12 | 3M创新有限公司 | 治疗耳感染的方法 |
| MX2007010904A (es) * | 2005-03-10 | 2007-12-05 | 3M Innovative Properties Co | Panuelo para mascota antimicrobiano. |
| US10918618B2 (en) | 2005-03-10 | 2021-02-16 | 3M Innovative Properties Company | Methods of reducing microbial contamination |
| MX2007010908A (es) | 2005-03-10 | 2007-12-05 | 3M Innovative Properties Co | Composiciones antimicrobianas que comprenden esteres de acidos hidroxicarboxilicos. |
| US9023891B2 (en) | 2008-05-29 | 2015-05-05 | Nevada Naturals, Inc. | Synergistic antimicrobial agents |
| US8999302B1 (en) * | 2009-10-22 | 2015-04-07 | Aplicare, Inc. | Skin dye protectant formulations |
| US8834857B1 (en) | 2011-01-18 | 2014-09-16 | Nevada Naturals Inc. | Deodorizing and skin cleaning |
| US10624368B1 (en) | 2018-02-01 | 2020-04-21 | Nevada Naturals Inc. | Control of pathogenic bacteria in foods |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3123528A (en) | 1964-03-03 | New therapeutic compositions | ||
| US4067997A (en) | 1975-05-21 | 1978-01-10 | Med-Chem Laboratories | Synergistic microbecidal composition and method |
| US4485029A (en) | 1984-03-19 | 1984-11-27 | Minnesota Mining And Manufacturing Company | Disinfecting method and compositions |
| US4921694A (en) | 1987-06-24 | 1990-05-01 | Beiersdorf Aktiengesellschaft | Deodorizing and antimicrobial composition for use in cosmetic or topical formulations |
| WO1993020812A1 (en) | 1992-04-14 | 1993-10-28 | Bioglan Ab | Potentiation of antimicrobial effects |
| DE4411664A1 (de) | 1994-04-05 | 1995-10-12 | Beiersdorf Ag | Neue desodorierende und antimikrobielle Zusammensetzungen zur Verwendung in kosmetischen oder topischen Zubereitungen |
| WO1996006153A2 (en) | 1994-08-25 | 1996-02-29 | Ciba Specialty Chemicals Holding Inc. | Surface-active formulations |
| WO1996018300A2 (en) | 1994-12-14 | 1996-06-20 | Alcide Corporation | Adherent disinfecting compositions and methods relating thereto |
| US5569461A (en) | 1995-02-07 | 1996-10-29 | Minnesota Mining And Manufacturing Company | Topical antimicrobial composition and method |
| WO1998009520A1 (en) | 1996-09-06 | 1998-03-12 | Minnesota Mining And Manufacturing Company | Antimicrobial compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69801820T2 (de) * | 1997-01-09 | 2002-04-11 | Bifodan As Hundested | Verwendung von Dichlorobenzyl Alkohol zur Herstellung einer Zusammenstellung zur topischen Behandlung von Entzündungen |
-
1999
- 1999-03-16 DE DE69905700T patent/DE69905700T2/de not_active Expired - Lifetime
- 1999-03-16 EP EP99907340A patent/EP1063886B1/en not_active Expired - Lifetime
- 1999-03-16 US US09/646,523 patent/US6414023B1/en not_active Expired - Lifetime
- 1999-03-16 EE EEP200000550A patent/EE04136B1/xx not_active IP Right Cessation
- 1999-03-16 CA CA002321658A patent/CA2321658C/en not_active Expired - Fee Related
- 1999-03-16 IL IL13789199A patent/IL137891A/xx not_active IP Right Cessation
- 1999-03-16 RU RU2000126306/15A patent/RU2221557C2/ru not_active IP Right Cessation
- 1999-03-16 PT PT99907340T patent/PT1063886E/pt unknown
- 1999-03-16 AU AU27142/99A patent/AU740138B2/en not_active Ceased
- 1999-03-16 DK DK99907340T patent/DK1063886T3/da active
- 1999-03-16 WO PCT/DK1999/000130 patent/WO1999046987A1/en active IP Right Grant
- 1999-03-16 AT AT99907340T patent/ATE233484T1/de active
- 1999-03-16 NZ NZ506681A patent/NZ506681A/xx not_active IP Right Cessation
- 1999-03-16 PL PL343030A patent/PL196077B1/pl unknown
- 1999-03-16 ES ES99907340T patent/ES2191417T3/es not_active Expired - Lifetime
-
2000
- 2000-08-22 LV LVP-00-112A patent/LV12582B/en unknown
- 2000-09-14 LT LT2000087A patent/LT4778B/lt not_active IP Right Cessation
- 2000-09-15 NO NO20004609A patent/NO323049B1/no not_active IP Right Cessation
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3123528A (en) | 1964-03-03 | New therapeutic compositions | ||
| US4067997A (en) | 1975-05-21 | 1978-01-10 | Med-Chem Laboratories | Synergistic microbecidal composition and method |
| US4485029A (en) | 1984-03-19 | 1984-11-27 | Minnesota Mining And Manufacturing Company | Disinfecting method and compositions |
| US4921694A (en) | 1987-06-24 | 1990-05-01 | Beiersdorf Aktiengesellschaft | Deodorizing and antimicrobial composition for use in cosmetic or topical formulations |
| WO1993020812A1 (en) | 1992-04-14 | 1993-10-28 | Bioglan Ab | Potentiation of antimicrobial effects |
| DE4411664A1 (de) | 1994-04-05 | 1995-10-12 | Beiersdorf Ag | Neue desodorierende und antimikrobielle Zusammensetzungen zur Verwendung in kosmetischen oder topischen Zubereitungen |
| WO1996006153A2 (en) | 1994-08-25 | 1996-02-29 | Ciba Specialty Chemicals Holding Inc. | Surface-active formulations |
| WO1996018300A2 (en) | 1994-12-14 | 1996-06-20 | Alcide Corporation | Adherent disinfecting compositions and methods relating thereto |
| US5569461A (en) | 1995-02-07 | 1996-10-29 | Minnesota Mining And Manufacturing Company | Topical antimicrobial composition and method |
| WO1998009520A1 (en) | 1996-09-06 | 1998-03-12 | Minnesota Mining And Manufacturing Company | Antimicrobial compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| EE04136B1 (et) | 2003-10-15 |
| DE69905700D1 (de) | 2003-04-10 |
| IL137891A (en) | 2005-03-20 |
| US6414023B1 (en) | 2002-07-02 |
| NO20004609L (no) | 2000-09-15 |
| DK1063886T3 (da) | 2003-06-23 |
| IL137891A0 (en) | 2001-10-31 |
| EP1063886A1 (en) | 2001-01-03 |
| DE69905700T2 (de) | 2003-11-13 |
| AU2714299A (en) | 1999-10-11 |
| NZ506681A (en) | 2002-12-20 |
| LV12582A (en) | 2000-12-20 |
| ATE233484T1 (de) | 2003-03-15 |
| LT2000087A (lt) | 2001-01-25 |
| EE200000550A (et) | 2002-04-15 |
| PT1063886E (pt) | 2003-07-31 |
| CA2321658C (en) | 2008-11-18 |
| WO1999046987A1 (en) | 1999-09-23 |
| RU2221557C2 (ru) | 2004-01-20 |
| LV12582B (en) | 2001-03-20 |
| AU740138B2 (en) | 2001-11-01 |
| CA2321658A1 (en) | 1999-09-23 |
| ES2191417T3 (es) | 2003-09-01 |
| EP1063886B1 (en) | 2003-03-05 |
| PL343030A1 (en) | 2001-07-30 |
| NO323049B1 (no) | 2006-12-27 |
| PL196077B1 (pl) | 2007-12-31 |
| NO20004609D0 (no) | 2000-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2221557C2 (ru) | Дезинфицирующий состав | |
| US6488942B1 (en) | Disinfecting agent | |
| US5651977A (en) | Adherent disinfecting compositions and methods relating thereto | |
| Hübner et al. | Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds | |
| US8043626B2 (en) | Fatty acid antimicrobial | |
| KR101534381B1 (ko) | 항균 조성물 | |
| US5569461A (en) | Topical antimicrobial composition and method | |
| US8778369B2 (en) | Barrier film-forming compositions and methods of use | |
| US20070249712A1 (en) | Peracetic teat dip | |
| US20060177518A1 (en) | Peracetic teat dip | |
| DE60320087T2 (de) | Wässriges antiseptikum auf der basis von bispyridiniumalkanen | |
| EP0744895B1 (en) | Adherent disinfecting compositions and methods relating thereto | |
| CN108697638A (zh) | 包含聚合双胍和edta的抗微生物清洁组合物 | |
| US5618841A (en) | Composition of iodophor teat dip for the prevention of mastitis and a process for using the same | |
| US9918991B2 (en) | Topical antimicrobial compositions and methods of using same | |
| US6107344A (en) | Aqueous germicidal film forming composition for applying to teats of dairy cows | |
| JPH0656675A (ja) | 家畜の乳房炎予防剤 | |
| JP2648886B2 (ja) | 家蓄の乳房炎を予防する方法 | |
| AU2002233873B2 (en) | Prophylactic teat treatment | |
| EP0692253A1 (en) | Prophylatic for domestic animal mastitis | |
| RU2088218C1 (ru) | Состав для обработки гигиенических салфеток | |
| JP3460366B2 (ja) | 口腔用組成物 | |
| CN116115532A (zh) | 一种抑菌祛味喷剂及其制备方法 | |
| CN118252760A (zh) | 一种消毒杀菌湿巾及其制备方法 | |
| CZ37412U1 (cs) | Dezinfekční přípravek |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM9A | Lapsed patents |
Effective date: 20140316 |